Latest News

The NCCN Guidelines now recommend scalp cooling

The NCCN Guidelines now recommend scalp cooling

The NCCN Guidelines now recommend scalp cooling as a category 2A treatment option for patients with invasive breast cancer The National Comprehensive Cancer Network® (NCCN®) has updated the Clinical Practice Guidelines in oncology for breast cancer...

read more
PAXMAN reaches milestone of 500 scalp cooling systems in the USA

PAXMAN reaches milestone of 500 scalp cooling systems in the USA

PAXMAN announces that the company now has installed or signed delivery agreements for just over 500 scalp cooling systems preventing hair loss in connection with chemotherapy in the USA, only two years after receiving FDA approval. The company is now actively supporting large-scale coverage and reimbursement for the treatment.
read more